Replies to post #2988 on CardioVascular BioTherapeutics (fka CVBT)

[SlalomKing]

I understand that Goldman Sachs have pleaded with Conman Dan to allow them to do an IPO in May to raise $3 billion valuing SHITTYA at $120 billion. They especially like SHITTYA because they have no patents, no clinical data, are led by a convicted fraudster* & have run afoul of the US FDA**

What a success story :-) :-) :-)

*Baraban Securities bankruptcy where Conman Dan was convicted of Fraud. See the Worst CEO video. Laments of a Bankrupted, Failed CEO

** The US FDA threw out SHITTYA's IND application for their Phase 1 trial due to dubious figures & claims which is why they are trying to do a trial in Mexico unsanctioned by the FDA.